SuperworthResMed shares outstanding RMD
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 145.1M
- On a year earlier
- −1.3%
- fewer shares
ResMed had 145.1M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 1.3% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 145.1M | −1% |
| FY2025 | 147.1M | −0% |
| FY2024 | 147.6M | −0% |
| FY2023 | 147.6M | +0% |
| FY2022 | 147.1M | +0% |
| FY2021 | 146.6M | +0% |
| FY2020 | 146.1M | +1% |
| FY2019 | 144.9M | +0% |
| FY2018 | 144.3M | +1% |
| FY2017 | 142.7M | +1% |
| FY2016 | 141.7M | −1% |
| FY2015 | 142.9M | −0% |
| FY2014 | 143.2M | −2% |
| FY2013 | 146.2M | −0% |
| FY2012 | 146.4M | −7% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 145.1M | −1% | |
| Q3 FY26 | 145.7M | −1% | |
| Q2 FY26 | 146.4M | −1% | |
| Q1 FY26 | 146.9M | −0% | |
| Q4 FY25 | 147.1M | −0% | |
| Q3 FY25 | 147.2M | −0% | |
| Q2 FY25 | 147.5M | −0% | |
| Q1 FY25 | 147.6M | +0% | |
| Q4 FY24 | 147.6M | −0% | |
| Q3 FY24 | 147.4M | +0% | |
| Q2 FY24 | 147.5M | +0% | |
| Q1 FY24 | 147.5M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ResMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.